BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17192423)

  • 1. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians.
    van der Steeg WA; Hovingh GK; Klerkx AH; Hutten BA; Nootenboom IC; Levels JH; van Tol A; Dallinga-Thie GM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA
    J Lipid Res; 2007 Mar; 48(3):674-82. PubMed ID: 17192423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.
    Cefalù AB; Noto D; Magnolo L; Pinotti E; Gomaraschi M; Martini S; Vigna GB; Calabresi L; Tarugi P; Averna MR
    Atherosclerosis; 2009 May; 204(1):202-7. PubMed ID: 18926541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
    Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
    Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
    Nagano M; Yamashita S; Hirano K; Takano M; Maruyama T; Ishihara M; Sagehashi Y; Kujiraoka T; Tanaka K; Hattori H; Sakai N; Nakajima N; Egashira T; Matsuzawa Y
    J Atheroscler Thromb; 2004; 11(3):110-21. PubMed ID: 15256762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
    Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
    J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
    Arai T; Yamashita S; Sakai N; Hirano K; Okada S; Ishigami M; Maruyama T; Yamane M; Kobayashi H; Nozaki S; Funahashi T; Kameda-Takemura K; Nakajima N; Matsuzawa Y
    J Lipid Res; 1996 Oct; 37(10):2145-54. PubMed ID: 8906592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia.
    Hirano K; Yamashita S; Funahashi T; Sakai N; Menju M; Ishigami M; Hiraoka H; Kameda-Takemura K; Tokunaga K; Hoshino T
    Atherosclerosis; 1993 Apr; 100(1):85-90. PubMed ID: 8318066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
    Inano K; Miida T; Okada M
    Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia.
    Plengpanich W; Siriwong S; Khovidhunkit W
    Metabolism; 2009 Aug; 58(8):1178-84. PubMed ID: 19428034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resequencing CETP, LIPC and LIPG genes in Thai subjects with hyperalphalipoproteinemia.
    Khovidhunkit W; Chartyingcharoen P; Siriwong S; Limumpornpetch P; Plengpanich W
    Am J Cardiol; 2012 Jul; 110(1):62-6. PubMed ID: 22464213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency.
    Chiba H; Akita H; Tsuchihashi K; Hui SP; Takahashi Y; Fuda H; Suzuki H; Shibuya H; Tsuji M; Kobayashi K
    J Lipid Res; 1997 Jun; 38(6):1204-16. PubMed ID: 9215548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
    Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
    Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and apoprotein composition of HDL in partial or complete CETP deficiency.
    Niesor EJ; von der Mark E; Calabresi L; Averna M; Cefalù AB; Tarugi P; Nilsson P; Dernick G
    Curr Vasc Pharmacol; 2012 Jul; 10(4):422-31. PubMed ID: 22339301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.
    Ohtani R; Inazu A; Noji Y; Wakasugi T; Miwa K; Tada H; Kawashiri MA; Noguchi T; Nohara A; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Clin Chim Acta; 2012 Mar; 413(5-6):537-43. PubMed ID: 22122993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.
    Kido T; Kurata H; Kondo K; Itakura H; Okazaki M; Urata T; Yokoyama S
    Sci Rep; 2016 Aug; 6():31532. PubMed ID: 27526664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
    Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.